For patients who have run out of approved treatment options, the outlook can feel frustrating, demoralizing, and even hopeless
But there are two programs that have helped thousands of patients gain new access to potentially life-saving experimental treatments: the Expanded Access Program (EAP) and the Right to Try law.
Educating physicians more on the program availability can lead to an increase in options for patients and a more positive outlook to recovery
Dr. Ajeet Gajra, Chief Medical Officer at Cardinal Health Specialty Solutions, joins us to discuss experimental oncology drug use through these programs. He’s on a mission to help uncover misconceptions and educate physicians on how feasible these options really are.
Here are the show highlights
- The Expanded Access Program (EAP) vs. the Right to Try law (5:41)
- Dr. Gajra’s research: Why do so few providers attempt these pathways? (13:06))
- How oncology staff can stay up-to-date on these programs (28:08)
- Tips to submit documents and support patients through the process (30:48)
- How success with these programs impacts the drug’s future use (33:15)
Check out these resources mentioned during the podcast:
Stay connected with Working in Oncology on Apple Podcasts, Spotify, or our podcast website.
Guest Bio
Dr. Ajeet Gajra, is a Medical Oncologist with over 28 years of experience. He is currently Chief Medical Officer at Cardinal Health Specialty Services.
